1024928

Progenics Pharmaceuticals, Inc. — FEI 3013080312

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 11, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New York, NY (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
748221 CFR 312.50General responsibilities of sponsors